Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temsirolimus With or Without Hormonal Therapy in Advanced Endometrial Carcinoma
NCT00729586Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2008
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in endometrial carcinoma, sponsored by National Cancer Institute. Started Sep 2008; status: completed.
02
Drugs
temsirolimus
03
Conditions
endometrial carcinoma
Beyond the preview
Go deeper on NCT00729586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00729586.